β-cell ABCA1 influences insulin secretion, glucose homeostasis and response to thiazolidinedione treatment

[1]  M. Hayden,et al.  Variations on a gene: rare and common variants in ABCA1 and their impact on HDL cholesterol levels and atherosclerosis. , 2006, Annual review of nutrition.

[2]  Albert K Groen,et al.  Intestinal ABCA1 directly contributes to HDL biogenesis in vivo. , 2006, The Journal of clinical investigation.

[3]  Jiwang Chen,et al.  Effect of cholesterol depletion on exocytosis of alveolar type II cells. , 2006, American journal of respiratory cell and molecular biology.

[4]  Joseph L. Goldstein,et al.  Protein Sensors for Membrane Sterols , 2006, Cell.

[5]  L. Mayorga,et al.  Cholesterol content regulates acrosomal exocytosis by enhancing Rab3A plasma membrane association. , 2005, Developmental biology.

[6]  R. Korneluk,et al.  The X-linked inhibitor of apoptosis protein enhances survival of murine islet allografts. , 2005, Diabetes.

[7]  Robert T. Kennedy,et al.  LXRβ Is Required for Adipocyte Growth, Glucose Homeostasis, and β Cell Function* , 2005, Journal of Biological Chemistry.

[8]  M. Hayden,et al.  Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I. , 2005, The Journal of clinical investigation.

[9]  M. Emi,et al.  Association of the PIK3C2G gene polymorphisms with type 2 DM in a Japanese population. , 2005, Biochemical and biophysical research communications.

[10]  C. Heaps,et al.  Hypercholesterolemia abolishes voltage-dependent K+ channel contribution to adenosine-mediated relaxation in porcine coronary arterioles. , 2005, American journal of physiology. Heart and circulatory physiology.

[11]  Paul T. Tarr,et al.  ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation. , 2005, Cell metabolism.

[12]  Jonathan C. Cohen,et al.  Multiple Rare Alleles Contribute to Low Plasma Levels of HDL Cholesterol , 2004, Science.

[13]  M. Wheeler,et al.  Disruption of Pancreatic β-Cell Lipid Rafts Modifies Kv2.1 Channel Gating and Insulin Exocytosis* , 2004, Journal of Biological Chemistry.

[14]  V. Mooser,et al.  Insulin-secreting β-Cell Dysfunction Induced by Human Lipoproteins* , 2003, The Journal of Biological Chemistry.

[15]  James D. Johnson,et al.  Increased islet apoptosis in Pdx1+/- mice. , 2003, The Journal of clinical investigation.

[16]  Z. Varghese,et al.  PPAR agonists protect mesangial cells from interleukin 1beta-induced intracellular lipid accumulation by activating the ABCA1 cholesterol efflux pathway. , 2003, Journal of the American Society of Nephrology : JASN.

[17]  M. Cnop,et al.  Low density lipoprotein can cause death of islet beta-cells by its cellular uptake and oxidative modification. , 2002, Endocrinology.

[18]  B. McManus,et al.  ABCA1 mRNA and Protein Distribution Patterns Predict Multiple Different Roles and Levels of Regulation , 2002, Laboratory Investigation.

[19]  S. Kahn,et al.  The Importance of β-Cell Failure in the Development and Progression of Type 2 Diabetes , 2001 .

[20]  R. Lawn,et al.  ABCA1. The gatekeeper for eliminating excess tissue cholesterol. , 2001, Journal of lipid research.

[21]  G. Gould,et al.  SNARE proteins are highly enriched in lipid rafts in PC12 cells: Implications for the spatial control of exocytosis , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[22]  G. Schmitz,et al.  Complete coding sequence, promoter region, and genomic structure of the human ABCA2 gene and evidence for sterol-dependent regulation in macrophages. , 2001, Biochemical and biophysical research communications.

[23]  J. Henquin,et al.  Triggering and amplifying pathways of regulation of insulin secretion by glucose. , 2000, Diabetes.

[24]  C. Gabel,et al.  High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[25]  L. Orci,et al.  Troglitazone prevents mitochondrial alterations, beta cell destruction, and diabetes in obese prediabetic rats. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[26]  T. Langmann,et al.  Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): evidence for sterol-dependent regulation in macrophages. , 1999, Biochemical and biophysical research communications.

[27]  M. Magnuson,et al.  Dual Roles for Glucokinase in Glucose Homeostasis as Determined by Liver and Pancreatic β Cell-specific Gene Knock-outs Using Cre Recombinase* , 1999, The Journal of Biological Chemistry.

[28]  J. Sawyer,et al.  Dietary monounsaturated fatty acids promote aortic atherosclerosis in LDL receptor-null, human ApoB100-overexpressing transgenic mice. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[29]  R. Unger,et al.  Fatty acid-induced β cell apoptosis: A link between obesity and diabetes , 1998 .

[30]  R. Unger,et al.  Troglitazone Lowers Islet Fat and Restores Beta Cell Function of Zucker Diabetic Fatty Rats* , 1998, The Journal of Biological Chemistry.

[31]  M. Byrne,et al.  Treatment with the oral antidiabetic agent troglitazone improves beta cell responses to glucose in subjects with impaired glucose tolerance. , 1997, The Journal of clinical investigation.

[32]  R. Unger.  Lipotoxicity in the Pathogenesis of Obesity-Dependent NIDDM: Genetic and Clinical Implications , 1995, Diabetes.

[33]  Yun-ping Zhou,et al.  Long term exposure to fatty acids and ketones inhibits B-cell functions in human pancreatic islets of Langerhans. , 1995, The Journal of clinical endocrinology and metabolism.

[34]  L. Rudel,et al.  Enzymatic determination of triglyceride, free cholesterol, and total cholesterol in tissue lipid extracts. , 1993, Clinical biochemistry.

[35]  D. Kipnis,et al.  Plasma insulin responses to oral and intravenous glucose: studies in normal and diabetic sujbjects. , 1967, The Journal of clinical investigation.

[36]  J. Gustafsson,et al.  LXRbeta is required for adipocyte growth, glucose homeostasis, and beta cell function. , 2005, The Journal of biological chemistry.

[37]  M. Muramatsu,et al.  Association of the ABCA1 gene polymorphisms with type 2 DM in a Japanese population. , 2005, Biochemical and biophysical research communications.

[38]  H. Minuk,et al.  Metabolic syndrome. , 2005, Journal of insurance medicine.

[39]  P. McTernan,et al.  The link between obesity and diabetes , 2004 .

[40]  V. Mooser,et al.  Insulin-secreting beta-cell dysfunction induced by human lipoproteins. , 2003, The Journal of biological chemistry.

[41]  R. Evans,et al.  A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. , 2001, Molecular cell.

[42]  M. Jaye,et al.  PPAR-α and PPAR-γ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway , 2001, Nature Medicine.

[43]  R. Evans,et al.  A PPARγ-LXR-ABCA1 Pathway in Macrophages Is Involved in Cholesterol Efflux and Atherogenesis , 2001 .

[44]  L. Bouwens,et al.  Endocytosis of low-density lipoprotein by human pancreatic beta cells and uptake in lipid-storing vesicles, which increase with age. , 2000, The American journal of pathology.

[45]  R. Unger,et al.  Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[46]  M. Cnop,et al.  Low density lipoprotein binding and uptake by human and rat islet beta cells. , 1997, Endocrinology.